Cosciens Biopharma Aktie
WKN DE: A40J1L / ISIN: CA22112H1010
26.05.2025 13:00:46
|
COSCIENS Biopharma To Review Director Nominations From Goodwood
(RTTNews) - COSCIENS Biopharma Inc. (CSCI, CSCI.TO) confirmed that it has received a letter from Goodwood Fund and Puccetti Funds Management Inc. regarding six director nominations for the Company's upcoming Annual and Special Meeting of Shareholders.
The company said its board will evaluate and determine its path forward and remains fully committed to acting in the best interests of COSCIENS and its shareholders.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cosciens Biopharma Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Cosciens Biopharma Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Cosciens Biopharma Inc Registered Shs | 2,24 | 0,90% |
|